Recruiting NA Depression

New treatment option for Depression

Official title TrueBlue Clinical Study - Investigating the Use of a Mobile Phone App TrueBlue for Monitoring Depression and Anxiety

ClinicalTrials.gov ID: NCT06364488

What this study is testing

What it's testing
This trial will assess the safety, feasibility, acceptability, usability and agreement with validated scales of an automated mood monitoring App (TrueBlue), in adult, perinatal participants (recruited between 12 weeks of pregnancy and 12 weeks post-partum), recruited across multiple sites in Nottinghamshire, United Kingdom (UK). An initial within-study pilot phase will assess key aspects of the study including recruitment rate, usability issues and a detailed understanding of any device related adverse events; prior to full recruitment of a total 125 participants over a total 14-month period.
  • Time commitment: about 12 weeks

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older, women only. Healthy volunteers may be eligible.

You may be able to join if

  • \- 18 years or older
  • Fluent in spoken and written English
  • Has capacity to provide consent
  • At least 12 weeks pregnant or less than 12 weeks postpartum
  • Access to internet connectivity

You likely can't join if

  • ● Current clinically diagnosed psychiatric disorder other than depression
  • Previous history of a clinically diagnosed psychiatric disorder, other than depression and generalised anxiety disorder (including previous...
  • Clinical diagnosis of an Autistic Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Parkinson's Disease or other current Neurological...
See the full eligibility criteria
Who can join
  • \- 18 years or older
  • Fluent in spoken and written English
  • Has capacity to provide consent
  • At least 12 weeks pregnant or less than 12 weeks postpartum
  • Access to internet connectivity
  • Access to a compatible smart phone device (for up to 10 participants, where needed through not having a personal device, this access may be provided through the study team).
  • Has a current GP within Nottinghamshire
What rules you out
  • ● Current clinically diagnosed psychiatric disorder other than depression
  • Previous history of a clinically diagnosed psychiatric disorder, other than depression and generalised anxiety disorder (including previous Psychosis, Bipolar Disorder, Personality Disorder, Substance Abuse Disorders...
  • Clinical diagnosis of an Autistic Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Parkinson's Disease or other current Neurological Disorder.

The study team makes the final eligibility decision.

Where it's taking place

  • Nottingham, Nottinghamshire, United Kingdom
  • Nottingham, United Kingdom

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Nottingham, Nottinghamshire, United Kingdom; Nottingham, United Kingdom. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.